Original language | English (US) |
---|---|
Pages (from-to) | S1-S3 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 19 |
DOIs | |
State | Published - Nov 2021 |
Bibliographical note
Funding Information:Disclosures: P.M. Cinciripini has disclosed receiving nonmonetary research support from Pfizer. G.W. Warren has disclosed participating in research for the Agency for Healthcare Research and Quality and serving as a consultant for the Canadian Partnership Against Cancer. The remaining individuals have disclosed no relevant financial relationships.
Funding Information:
Funding: This supplement was funded by the C3I Coordinating Center contract from the National Cancer Institute (CRDF Award #66590). In addition, authors received funding for their C3I participation via a supplement to their NCI P30 cancer center support grant during the period 2017–2021.